Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
Showing 19,281 - 19,300 results of 105,995 for search '(( a fold decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.70s Refine Results
  1. 19281
    Innate and adaptive immune cell activation in response to ex vivo VZV-gE stimulation in RZV recipients.

    Innate and adaptive immune cell activation in response to ex vivo VZV-gE stimulation in RZV recipients. by Michael J. Johnson (5818168)

    Published 2025
    Save to List
    Saved in:
  2. 19282
    Homologous (VZV-gE) and heterologous (HSV, HCMV) Monocyte and NK memory-like immune responses after RZV administration.

    Homologous (VZV-gE) and heterologous (HSV, HCMV) Monocyte and NK memory-like immune responses after RZV administration. by Michael J. Johnson (5818168)

    Published 2025
    Save to List
    Saved in:
  3. 19283
    Determination of biochemical indicators (n = 6).

    Determination of biochemical indicators (n = 6). by Ying Shen (48310)

    Published 2024
    “…<p>a: levels of reproductive hormones in serum, in the model, LH, FSH, and PRL levels significantly increased, while GnRH, T, and E<sub>2</sub> levels decreased, indicating a hormonal imbalance compared to controls; b: changes in neurotransmitters in serum, serum levels of 5-HT and NE significantly decreased in the model, with 5-HT reduction being greater than NE. …”
    Save to List
    Saved in:
  4. 19284
    Peripheral blood innate and adaptive T cell responses to zoster vaccines.

    Peripheral blood innate and adaptive T cell responses to zoster vaccines. by Michael J. Johnson (5818168)

    Published 2025
    Save to List
    Saved in:
  5. 19285
    Altering the demand for PRPP modulates the sensitivity to Cu(II).

    Altering the demand for PRPP modulates the sensitivity to Cu(II). by Javiera Norambuena (137228)

    Published 2023
    Save to List
    Saved in:
  6. 19286
    Fig 4 -

    Fig 4 - by Zixiang Wang (7548716)

    Published 2024
    Save to List
    Saved in:
  7. 19287
    S1 Data -

    S1 Data - by Zixiang Wang (7548716)

    Published 2024
    “…The two groups of rats were observed and compared for PVT formation at 1, 3 and 5 days after modeling, respectively.</p><p>Results</p><p>A stable rat PVT model was successfully constructed. …”
    Save to List
    Saved in:
  8. 19288
    Characteristics of the study population according to physical activity at enrollment<sup>b'*'</sup>.

    Characteristics of the study population according to physical activity at enrollment<sup>b'*'</sup>. by Ronit Calderon-Margalit (584756)

    Published 2025
    Save to List
    Saved in:
  9. 19289
    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…The best analogs increased selectivity of CYP17A1 inhibition up to 84-fold compared with 6.6-fold for abiraterone. …”
    Save to List
    Saved in:
  10. 19290
    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…The best analogs increased selectivity of CYP17A1 inhibition up to 84-fold compared with 6.6-fold for abiraterone. …”
    Save to List
    Saved in:
  11. 19291
    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…The best analogs increased selectivity of CYP17A1 inhibition up to 84-fold compared with 6.6-fold for abiraterone. …”
    Save to List
    Saved in:
  12. 19292
    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…The best analogs increased selectivity of CYP17A1 inhibition up to 84-fold compared with 6.6-fold for abiraterone. …”
    Save to List
    Saved in:
  13. 19293
    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…The best analogs increased selectivity of CYP17A1 inhibition up to 84-fold compared with 6.6-fold for abiraterone. …”
    Save to List
    Saved in:
  14. 19294
    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…The best analogs increased selectivity of CYP17A1 inhibition up to 84-fold compared with 6.6-fold for abiraterone. …”
    Save to List
    Saved in:
  15. 19295
    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…The best analogs increased selectivity of CYP17A1 inhibition up to 84-fold compared with 6.6-fold for abiraterone. …”
    Save to List
    Saved in:
  16. 19296
    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…The best analogs increased selectivity of CYP17A1 inhibition up to 84-fold compared with 6.6-fold for abiraterone. …”
    Save to List
    Saved in:
  17. 19297
    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…The best analogs increased selectivity of CYP17A1 inhibition up to 84-fold compared with 6.6-fold for abiraterone. …”
    Save to List
    Saved in:
  18. 19298
    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…The best analogs increased selectivity of CYP17A1 inhibition up to 84-fold compared with 6.6-fold for abiraterone. …”
    Save to List
    Saved in:
  19. 19299
    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…The best analogs increased selectivity of CYP17A1 inhibition up to 84-fold compared with 6.6-fold for abiraterone. …”
    Save to List
    Saved in:
  20. 19300
    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…The best analogs increased selectivity of CYP17A1 inhibition up to 84-fold compared with 6.6-fold for abiraterone. …”
    Save to List
    Saved in:

Search Tools: